These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Proceedings: Effect of alufibrate (Atherolip) on pyruvate and lipoprotein metabolism in patients with hyperlipidemia type IV]. Stähelin HB; Locher JT; Maier R Helv Med Acta; 1974 May; 37(5-6):388-9. PubMed ID: 4153233 [No Abstract] [Full Text] [Related]
3. [Advances in lipoprotein research: biochemical and clinical aspects (author's transl)]. Schettler G; Seidel D; Greten H Folia Clin Int (Barc); 1974 May; 24(5):357-68. PubMed ID: 4408506 [No Abstract] [Full Text] [Related]
8. The lipoprotein apoproteins. Their role in normal lipid transport and dyslipoproteinemia. Levy RI; Eisenberg S Ann Biol Clin (Paris); 1974; 32(1):1-8. PubMed ID: 4366057 [No Abstract] [Full Text] [Related]
9. Pathophysiology of lipid transport disorders. Levy RI Postgrad Med J; 1975; 51(8):16-26. PubMed ID: 1221376 [No Abstract] [Full Text] [Related]
10. [Physiopathology and clinical aspects of lipid metabolism disorders. Physiopathology of lipid metabolism from the clinical viewpoint]. Haller H; Hanefeld M; Leonhardt W Dtsch Gesundheitsw; 1971 Sep; 26(36):1673-9. PubMed ID: 4940280 [No Abstract] [Full Text] [Related]
11. [Lipoprotein metabolism in the blood plasma and liver in alimentary dyslipoproteinemias in an experiment]. Liapkov BG Vopr Pitan; 1985; (5):32-7. PubMed ID: 4082518 [TBL] [Abstract][Full Text] [Related]
12. [Principles of cooperation between the Medical Center for Postgraduate Education, medical academies and scientific research institutes in postgraduate medical education]. Ruzyllo E Pol Tyg Lek; 1972 Jan; 27(3):115-8. PubMed ID: 5060039 [No Abstract] [Full Text] [Related]
13. [Flotation analysis studies of lipoproteins in correlation with the lipid pattern in essential hyperlipemia and diabetic metabolism status]. Haller H; Hanefeld H; Kretschmar R; Unger E; Arnold F; Wagner B Schweiz Med Wochenschr; 1969 May; 99(22):813-5. PubMed ID: 5802001 [No Abstract] [Full Text] [Related]
14. [Physiopathology and clinical aspects of lipid metabolism disorders. Clinical aspects and therapy of primary hyperlipoproteinemias]. Haller H; Hanefeld M; Leonhardt W Dtsch Gesundheitsw; 1971 Sep; 26(37):1721-6. PubMed ID: 5122707 [No Abstract] [Full Text] [Related]
15. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484 [TBL] [Abstract][Full Text] [Related]
16. Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats. Segal P; Roheim PS; Eder HA J Clin Invest; 1972 Jul; 51(7):1632-8. PubMed ID: 4338117 [TBL] [Abstract][Full Text] [Related]
17. [Lipoprotein metabolism--physiological and clinical aspects. Occurrence, distribution and composition of lipids in the human body]. Cichocki T; Litwin JA Przegl Lek; 1976; 33(4):468-73. PubMed ID: 1273344 [No Abstract] [Full Text] [Related]
18. Beta lipoprotein protein turnover: an approach to the understanding of drug and disease mechanisms. Levy RI Expos Annu Biochim Med; 1972; 31():91-6. PubMed ID: 4350392 [No Abstract] [Full Text] [Related]
19. Xanthomas: a marker for hyperlipidemias. Lugo-Somolinos A; Sánchez JE Bol Asoc Med P R; 2003; 95(4):12-6. PubMed ID: 15032023 [TBL] [Abstract][Full Text] [Related]
20. [Postgraduate medical training in Poland. The 3 stages]. Ruzyllo E Lakartidningen; 1966 Mar; 63(11):1054-6. PubMed ID: 5917914 [No Abstract] [Full Text] [Related] [Next] [New Search]